Xcout Intel
Paratus Sciences
Paratus Sciences is a biopharmaceutical company headquartered in Boston, Massachusetts, with research operations in Singapore, focused on translating evolutionary insights into first-in-class medicines.
Subscribe to see Paratus Sciences’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Paratus Sciences at a glance
Paratus Sciences is a biotech company headquartered in United States. Its most recent funding round, Series A, raised $100M in February 2023. Xcout tracks 15 named people at Paratus Sciences, including Alicia Secor (President & Chief Executive Officer).
Paratus Sciences leadership
- Alicia SecorPresident & Chief Executive Officer
- Jeffrey YoungChief Financial Officer
- Mark CockettChief Scientific Officer
- Dhavalkumar Patel, MD, PhDChair
- Paul MatsudairaCo-founder, Paratus
- Richard YoungCo-founder, Paratus Whitehead Institute
9 more named people on record for Paratus Sciences, with roles, board committees and tenure — see the full roster →
Paratus Sciences funding rounds
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series A | $100M | 7 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Investors
Paratus Sciences competitors
A few of Paratus Sciences's closest competitors — see the full list of competitors and alternatives →
Hummingbird Bioscience is a precision biotherapeutics company located in Singapore. It focuses on discovering and developing engineered precision biotherapeutics to define the future of precision medicine.
Red Queen Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on antiviral therapeutics, with its headquarters located in Cambridge, Massachusetts.
Engine Biosciences is a Singapore-based biotechnology company and venture-creation platform that combines machine learning, computational biology, and laboratory experimentation to discover and develop new medicines. It builds and invests in therapeutic-focused biotech companies, serving pharmaceutical and healthcare markets.
Senda Biosciences is a biotechnology company focused on harnessing nature to program novel medicines, headquartered in Cambridge, Massachusetts.
Pretzel Therapeutics is a biotechnology company headquartered in Boston, Massachusetts, advancing a new class of medicines that target cellular energetics and mitochondrial function.
Bambusa Therapeutics is a biotechnology research company with roots in Victoria, Australia, and an office in Boston, Massachusetts. It focuses on biotech research and development.
Get Paratus Sciences's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Paratus Sciences in Xcout Intel
- 15 named people with titles, LinkedIn and board committees
- 1 funding round with the investors in each, and who they co-invest with
- The full competitor set, tracking, exports and API access